Pfizer invests $150m for microbial resistance
Pfizer Australia has announced a major upgrade to its manufacturing facility in Melbourne to boost production of pharmaceuticals aiming to help address rising levels of antimicrobial resistance. Pfizer has invested $150 million to develop advanced pharmaceutical production facilities for new antimicrobial treatments tackling what is one of the biggest threats to global health. The Victorian…